Discovery of potential syringic acid (SA) derived "BH3 mimetics" A novel approach to cancer drug discovery
-
- Englisch ausgewählt
Fr. 62.90
inkl. gesetzl. MwSt.,
Beschreibung
Produktdetails
Einband
Taschenbuch
Erscheinungsdatum
23.03.2018
Verlag
Scholar's PressSeitenzahl
56
Maße (L/B/H)
22/15/0.4 cm
Gewicht
102 g
Auflage
1. Auflage
Sprache
Englisch
ISBN
978-620-2-30953-0
Despite incredible advancement made in recent years, treatment of cancer still remains the most challenging task for the mankind. The apoptotic cell death program serves as a natural barrier to tumor development. Evading this program is a hallmark of cancer and constitutes an important mechanism in therapeutic resistance. This prompted the development of novel anticancer strategies targeting apoptosis. The pro-apoptotic Bcl-2 protein BAX by itself is sufficient to initiate apoptosis in almost all apoptotic paradigms. Thus, compounds that can facilitate disruptive Bax insertion into mitochondrial membranes have potential as cancer therapeutics.Natural compounds have historically been a mainstay source of anticancer drugs. This book, therefore provides new ideas to discovery of natural compound based anticancer agents through virtual screening approach. Computational docking studies of BAX and proposed syringic acid analogs suggested the way to find potential target leads as anticancer agents. In silico mutation and comparative binding studies may provide a good idea to find "BH3 mimetics".
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.